Pharming Group N.V. Investment Income
Pharming Group N.V. (PHAR) reported Investment Income of $2.18 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-02.
Financial Statements › Income Statement › Other Income
ifrs-full:InvestmentIncome · last filed 2026-04-02
EUR
| Period end | Investment Income 12 month |
|---|---|
| 2020-12-31 | 626.00K EUR 20-F · filed 2021-04-07 |
| 2019-12-31 | 1.01M EUR 20-F · filed 2021-04-07 |
| 2018-12-31 | 18.00K EUR 20-F · filed 2021-04-07 |
USD
| Period end | Investment Income 12 month |
|---|---|
| 2025-12-31 | $2.18M 20-F · filed 2026-04-02 |
| 2024-12-31 | $4.86M 20-F · filed 2026-04-02 |
| 2023-12-31 | $3.66M 20-F · filed 2026-04-02 |
| 2022-12-31 | $85.00K 20-F · filed 2025-04-03 |
| 2021-12-31 | $53.00K 20-F · filed 2024-04-04 |
| 2020-12-31 | $715.00K 20-F · filed 2023-04-05 |
| 2019-12-31 | $1.13M 20-F · filed 2022-04-06 |